"Spot Sign" Selection of Intracerebral Hemorrhage to Guide Hemostatic Therapy
Clinical trial NCT01359202 · COMPLETED
Trial details
- NCT number
- NCT01359202
- Sponsor
- Dr. David Gladstone
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2018-06-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.